Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1982 Dec;77(Suppl):445P–597P.

Proceedings of the British Pharmacological Society 8th-10th September, 1982. Abstracts.

PMCID: PMC2044581  PMID: 7150878

Full text

PDF
445P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambache N., Zar M. A. Non-cholinergic transmission by post-ganglionic motor neurones in the mammalian bladder. J Physiol. 1970 Oct;210(3):761–783. doi: 10.1113/jphysiol.1970.sp009240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnett D. B., Rugg E. L., Nahorski S. R. Direct evidence of two types of beta adrenoceptor binding site in lung tissue. Nature. 1978 May 11;273(5658):166–168. doi: 10.1038/273166a0. [DOI] [PubMed] [Google Scholar]
  3. Bax N. D., Lennard M. S., Tucker G. T. Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists. Br J Clin Pharmacol. 1981 Dec;12(6):779–784. doi: 10.1111/j.1365-2125.1981.tb01306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bennett A., Jarosik C., Sanger G. J., Wilson D. E. Antagonism of prostanoid-induced contractions of rat gastric fundus muscle by SC-19220, sodium meclofenamate, indomethacin or trimethoquinol. Br J Pharmacol. 1980;71(1):169–175. doi: 10.1111/j.1476-5381.1980.tb10922.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berridge M. J. Phosphatidylinositol hydrolysis: a multifunctional transducing mechanism. Mol Cell Endocrinol. 1981 Nov;24(2):115–140. doi: 10.1016/0303-7207(81)90055-1. [DOI] [PubMed] [Google Scholar]
  6. Birdsall N. J., Burgen A. S., Hulme E. C. The binding of agonists to brain muscarinic receptors. Mol Pharmacol. 1978 Sep;14(5):723–736. [PubMed] [Google Scholar]
  7. Burgess G. M., Claret M., Jenkinson D. H. Effects of quinine and apamin on the calcium-dependent potassium permeability of mammalian hepatocytes and red cells. J Physiol. 1981 Aug;317:67–90. doi: 10.1113/jphysiol.1981.sp013814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burnstock G., Cocks T., Crowe R. Evidence for purinergic innervation of the anococcygeus muscle. Br J Pharmacol. 1978 Sep;64(1):13–20. doi: 10.1111/j.1476-5381.1978.tb08635.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Burnstock G., Dumsday B., Smythe A. Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol. 1972 Mar;44(3):451–461. doi: 10.1111/j.1476-5381.1972.tb07283.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chignard M., Le Couedic J. P., Tence M., Vargaftig B. B., Benveniste J. The role of platelet-activating factor in platelet aggregation. Nature. 1979 Jun 28;279(5716):799–800. doi: 10.1038/279799a0. [DOI] [PubMed] [Google Scholar]
  11. Chiou C. Y., Long J. P. Acetylcholine-releasing effects of some nicotinic agents on chick biventer cervicis nerve muscle preparation. Proc Soc Exp Biol Med. 1969 Nov;132(2):732–737. doi: 10.3181/00379727-132-34299. [DOI] [PubMed] [Google Scholar]
  12. Churchill P. C. Calcium dependency of the inhibitory effect of antidiuretic hormone on in vitro renin secretion in rats. J Physiol. 1981 Jun;315:21–30. doi: 10.1113/jphysiol.1981.sp013729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Costall B., Lim S. K., Naylor R. J. Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice. Eur J Pharmacol. 1981 Jul 17;73(2-3):175–188. doi: 10.1016/0014-2999(81)90089-3. [DOI] [PubMed] [Google Scholar]
  14. Crema A., Del Tacca M., Frigo G. M., Lecchini S. Presence of a non-adrenergic inhibitory system in the human colon. Gut. 1968 Dec;9(6):633–637. doi: 10.1136/gut.9.6.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cseuz R., Wenger T. L., Kunos G., Szentiványi M. Changes of adrenergic reaction pattern in experimental diabetes mellitus. Endocrinology. 1973 Sep;93(3):752–755. doi: 10.1210/endo-93-3-752. [DOI] [PubMed] [Google Scholar]
  16. Dawbarn D., Pycock C. J. Lesions of the superior colliculus in the rat differentiate between nigrostriatal and mesolimbic dopamine systems. Brain Res. 1982 Mar 4;235(1):148–155. doi: 10.1016/0006-8993(82)90205-0. [DOI] [PubMed] [Google Scholar]
  17. Deacon C. S., Lennard M. S., Bax N. D., Woods H. F., Tucker G. T. Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility. Br J Clin Pharmacol. 1981 Sep;12(3):429–431. doi: 10.1111/j.1365-2125.1981.tb01240.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Di Salle E., Baker K. M., Bareggi S. R., Watkins W. D., Chidsey C. A., Frigerio A., Morselli P. L. A sensitive gas chromatographic method for the determination of propranolol in human plasma. J Chromatogr. 1973 Sep 26;84(2):347–353. doi: 10.1016/s0021-9673(01)91714-5. [DOI] [PubMed] [Google Scholar]
  19. Doggrell S. A. Prazosin selectively inhibits the responses to field stimulation in the rat vas deferens. Eur J Pharmacol. 1981 May 22;71(4):447–453. doi: 10.1016/0014-2999(81)90189-8. [DOI] [PubMed] [Google Scholar]
  20. Ernst A. M. Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS. Psychopharmacologia. 1965 May 21;7(6):391–399. doi: 10.1007/BF00402361. [DOI] [PubMed] [Google Scholar]
  21. Fanselow M. S., Bolles R. C. Naloxone and shock-elicited freezing in the rat. J Comp Physiol Psychol. 1979 Aug;93(4):736–744. doi: 10.1037/h0077609. [DOI] [PubMed] [Google Scholar]
  22. Farnebo L. O., Malamfors T. 3 H-noradrenaline release and mechanical response in the field stimulated mouse vas deferens. Acta Physiol Scand Suppl. 1971;371:1–18. doi: 10.1111/j.1748-1716.1971.tb05210.x. [DOI] [PubMed] [Google Scholar]
  23. French A. M., Scott N. C. A comparison of the effects of nifedipine and verapamil on rat vas deferens. Br J Pharmacol. 1981 Jun;73(2):321–323. doi: 10.1111/j.1476-5381.1981.tb10424.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. GRAY E. G., WHITTAKER V. P. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat. 1962 Jan;96:79–88. [PMC free article] [PubMed] [Google Scholar]
  25. Gillespie J. S. The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br J Pharmacol. 1972 Jul;45(3):404–416. doi: 10.1111/j.1476-5381.1972.tb08097.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Gorrod J. W., Temple D. J., Beckett A. H. The metabolism of N-ethyl-N-methylaniline by rabbit liver microsomes: the measurement of metabolites by gas-liquid chromatography. Xenobiotica. 1975 Aug;5(8):453–463. doi: 10.3109/00498257509056116. [DOI] [PubMed] [Google Scholar]
  27. Goyal R. K., Rattan S. Neurohumoral, hormonal, and drug receptors for the lower esophageal sphincter. Gastroenterology. 1978 Mar;74(3):598–619. [PubMed] [Google Scholar]
  28. Habig W. H., Pabst M. J., Jakoby W. B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974 Nov 25;249(22):7130–7139. [PubMed] [Google Scholar]
  29. Hagan R. M., Hughes I. E. Effect of noradrenaline reuptake blockade on evoked tritium overflow from mouse vasa deferentia and rat cortex slices previously incubated with 3H-noradrenaline. J Auton Pharmacol. 1981 Dec;1(5):385–390. doi: 10.1111/j.1474-8673.1981.tb00077.x. [DOI] [PubMed] [Google Scholar]
  30. Hallberg H., Almgren O., Svensson T. H. Increased brain serotonergic and noradrenergic activity after repeated systemic administration of the beta-2 adrenoceptor agonist salbutamol, a putative antidepressant drug. Psychopharmacology (Berl) 1981;73(3):201–204. doi: 10.1007/BF00422402. [DOI] [PubMed] [Google Scholar]
  31. Hammer R., Berrie C. P., Birdsall N. J., Burgen A. S., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 1980 Jan 3;283(5742):90–92. doi: 10.1038/283090a0. [DOI] [PubMed] [Google Scholar]
  32. Hems R., Ross B. D., Berry M. N., Krebs H. A. Gluconeogenesis in the perfused rat liver. Biochem J. 1966 Nov;101(2):284–292. doi: 10.1042/bj1010284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hulme E. C., Birdsall N. J., Burgen A. S., Mehta P. The binding of antagonists to brain muscarinic receptors. Mol Pharmacol. 1978 Sep;14(5):737–750. [PubMed] [Google Scholar]
  34. Hunkeler W., Möhler H., Pieri L., Polc P., Bonetti E. P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepines. Nature. 1981 Apr 9;290(5806):514–516. doi: 10.1038/290514a0. [DOI] [PubMed] [Google Scholar]
  35. Ikeda Y., Kikuchi M., Toyama K., Watanabe K., Ando Y. Inhibition of human platelet functions by verapamil. Thromb Haemost. 1981 Apr 30;45(2):158–161. [PubMed] [Google Scholar]
  36. Ito Y., Suzuki H., Kuriyama H. Effects of sodium nitroprusside on smooth muscle cells of rabbit pulmonary artery and portal vein. J Pharmacol Exp Ther. 1978 Dec;207(3):1022–1031. [PubMed] [Google Scholar]
  37. Jackson C. V., Carrier G. O. Supersensitivity of isolated mesenteric arteries to noradrenaline in the long-term experimental diabetic rat. J Auton Pharmacol. 1981 Dec;1(5):399–405. doi: 10.1111/j.1474-8673.1981.tb00079.x. [DOI] [PubMed] [Google Scholar]
  38. Jolly S. R., Lech J. J., Menahan L. A. Comparison of isoproterenol, salbutamol and tazolol as lipolytic agents with isolated rodent adipocytes. Biochem Pharmacol. 1978;27(14):1885–1887. doi: 10.1016/0006-2952(78)90039-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Komiskey H. L., Bossart J. F., Miller D. D., Patil P. N. Conformation of dopamine at the dopamine receptor. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2641–2643. doi: 10.1073/pnas.75.6.2641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Krell R. D., Mccoy J. L., Ridley P. T. Pharmacological characterization of the excitatory innervation to the guinea-pig urinary bladder in vitro: evidence for both cholinergic and non-adrenergic-non-cholinergic neurotransmission. Br J Pharmacol. 1981 Sep;74(1):15–22. doi: 10.1111/j.1476-5381.1981.tb09950.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
  42. Langer S. Z., Massingham R., Shepperson N. B. Presence of postsynaptic alpha 2-adrenoreceptors of predominantly extrasynaptic location in the vascular smooth muscle of the dog hind limb. Clin Sci (Lond) 1980 Dec;59 (Suppl 6):225s–228s. doi: 10.1042/cs059225s. [DOI] [PubMed] [Google Scholar]
  43. Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacol Rev. 1980 Dec;32(4):337–362. [PubMed] [Google Scholar]
  44. Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacol Rev. 1980 Dec;32(4):337–362. [PubMed] [Google Scholar]
  45. Langley J. N., Anderson H. K. The Innervation of the Pelvic and adjoining Viscera: Part II. The Bladder. Part III. The External Generative Organs. Part IV. The Internal Generative Organs. Part V. Position of the Nerve Cells on the Course of the Efferent Nerve Fibres. J Physiol. 1895 Dec 30;19(1-2):71–139. doi: 10.1113/jphysiol.1895.sp000587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Lecrubier Y., Puech A. J., Jouvent R., Simon P., Widlocher D. A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study. Br J Psychiatry. 1980 Apr;136:354–358. doi: 10.1192/bjp.136.4.354. [DOI] [PubMed] [Google Scholar]
  47. MCGREGOR D. D. THE EFFECT OF SYMPATHETIC NERVE STIMULATION OF VASOCONSTRICTOR RESPONSES IN PERFUSED MESENTERIC BLOOD VESSELS OF THE RAT. J Physiol. 1965 Mar;177:21–30. doi: 10.1113/jphysiol.1965.sp007572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Marshall I. G. Actions of acetylcholine and carbachol on the chick biventer cervicis muscle. Br J Pharmacol. 1971 Jul;42(3):462–472. doi: 10.1111/j.1476-5381.1971.tb07131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. McCalden T. A. Sympathetic control of the cerebral circulation. J Auton Pharmacol. 1981 Dec;1(5):421–431. doi: 10.1111/j.1474-8673.1981.tb00082.x. [DOI] [PubMed] [Google Scholar]
  50. McGrath J. C. Adrenergic and 'non-adrenergic' components in the contractile response of the vas deferens to a single indirect stimulus. J Physiol. 1978 Oct;283:23–39. doi: 10.1113/jphysiol.1978.sp012486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. McGrath J. C. Adrenergic and 'non-adrenergic' components in the contractile response of the vas deferens to a single indirect stimulus. J Physiol. 1978 Oct;283:23–39. doi: 10.1113/jphysiol.1978.sp012486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Mefford I. N. Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J Neurosci Methods. 1981 Feb;3(3):207–224. doi: 10.1016/0165-0270(81)90056-x. [DOI] [PubMed] [Google Scholar]
  53. Mimnaugh E. G., Trush M. A., Ginsburg E., Hirokata Y., Gram T. E. The effects of adriamycin in vitro and in vivo on hepatic microsomal drug-metabolizing enzymes: role of microsomal lipid peroxidation. Toxicol Appl Pharmacol. 1981 Dec;61(3):313–325. doi: 10.1016/0041-008x(81)90352-5. [DOI] [PubMed] [Google Scholar]
  54. Myers C. E., McGuire W. P., Liss R. H., Ifrim I., Grotzinger K., Young R. C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science. 1977 Jul 8;197(4299):165–167. doi: 10.1126/science.877547. [DOI] [PubMed] [Google Scholar]
  55. Nebert D. W., Gelboin H. V. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J Biol Chem. 1968 Dec 10;243(23):6242–6249. [PubMed] [Google Scholar]
  56. Owen M. P., Carrier G. O. Calcium dependence of norepinephrine-induced vascular contraction in experimental diabetes. J Pharmacol Exp Ther. 1980 Feb;212(2):253–258. [PubMed] [Google Scholar]
  57. Owen N. E., Le Breton G. C. Ca2+ mobilization in blood platelets as visualized by chlortetracycline fluorescence. Am J Physiol. 1981 Oct;241(4):H613–H619. doi: 10.1152/ajpheart.1981.241.4.H613. [DOI] [PubMed] [Google Scholar]
  58. Palacios J. M., Garbarg M., Barbin G., Schwartz J. C. Pharmacological characterization of histamine receptors mediating the stimulation of cyclic AMP accumulation in slices from guinea-pig hippocampus. Mol Pharmacol. 1978 Nov;14(6):971–982. [PubMed] [Google Scholar]
  59. Parsons M. E., Owen D. A., Ganellin C. R., Durant G. J. Dimaprit -(S-[3-(N,N-dimethylamino)prophyl]isothiourea) - a highly specific histamine H2 -receptor agonist. Part 1. Pharmacology. Agents Actions. 1977 Mar;7(1):31–37. doi: 10.1007/BF01964878. [DOI] [PubMed] [Google Scholar]
  60. Phillipson O. T. Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: a horseradish peroxidase study in the rat. J Comp Neurol. 1979 Sep 1;187(1):117–143. doi: 10.1002/cne.901870108. [DOI] [PubMed] [Google Scholar]
  61. Piafsky K. M., Borgá O., Odar-Cederlöf I., Johansson C., Sjöqvist F. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med. 1978 Dec 28;299(26):1435–1439. doi: 10.1056/NEJM197812282992604. [DOI] [PubMed] [Google Scholar]
  62. Pirch J. H. Amphetamine effects on brain slow potentials associated with discrimination in the rat. Pharmacol Biochem Behav. 1977 Jun;6(6):697–700. doi: 10.1016/0091-3057(77)90097-1. [DOI] [PubMed] [Google Scholar]
  63. Pirch J. H. Effects of amphetamine and chlorpromazine on brain slow potentials in the rat. Pharmacol Res Commun. 1977 Jul;9(7):669–674. doi: 10.1016/s0031-6989(77)80097-0. [DOI] [PubMed] [Google Scholar]
  64. ROSZKOWSKI A. P. An unusual type of sympathetic ganglionic stimulant. J Pharmacol Exp Ther. 1961 May;132:156–170. [PubMed] [Google Scholar]
  65. Redgrave P., Dean P., Donohoe T. P., Pope S. G. Superior colliculus lesions selectively attenuate apomorphine-induced oral stereotypy: a possible role for the nigrotectal pathway. Brain Res. 1980 Sep 8;196(2):541–546. doi: 10.1016/0006-8993(80)90422-9. [DOI] [PubMed] [Google Scholar]
  66. Rodgers R. J., Deacon R. M. Footshock-analgesia: prevention by behavioural manipulation but not by naloxone. Physiol Behav. 1981 Feb;26(2):183–187. doi: 10.1016/0031-9384(81)90008-1. [DOI] [PubMed] [Google Scholar]
  67. Rosenblatt J. E., Shore D., Wyatt R. J., Pert C. B. Increased renal neuroleptic binding in spontaneously hypertensive rats. Eur J Pharmacol. 1980 Oct 17;67(2-3):317–320. doi: 10.1016/0014-2999(80)90516-6. [DOI] [PubMed] [Google Scholar]
  68. Routledge P. A., Barchowsky A., Bjornsson T. D., Kitchell B. B., Shand D. G. Lidocaine plasma protein binding. Clin Pharmacol Ther. 1980 Mar;27(3):347–351. doi: 10.1038/clpt.1980.46. [DOI] [PubMed] [Google Scholar]
  69. Schneck D. W., Pritchard J. F. The inhibitory effect of propranolol pretreatment on its own metabolism in the rat. J Pharmacol Exp Ther. 1981 Sep;218(3):575–581. [PubMed] [Google Scholar]
  70. Scholfield C. N. Antagonism of gamma-aminobutyric acid and muscimol by picrotoxin, bicuculline, strychnine, bemegride, leptazol, D-tubocurarine and theophylline in the isolated olfactory cortex. Naunyn Schmiedebergs Arch Pharmacol. 1982 Mar;318(4):274–280. doi: 10.1007/BF00501165. [DOI] [PubMed] [Google Scholar]
  71. Seeman P. Brain dopamine receptors. Pharmacol Rev. 1980 Sep;32(3):229–313. [PubMed] [Google Scholar]
  72. Shaw J. O., Henson P. M. The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets. Am J Pathol. 1980 Mar;98(3):791–810. [PMC free article] [PubMed] [Google Scholar]
  73. Shepperson N. B., Duval N., Massingham R., Langer S. Z. Differential blocking effects of several dopamine receptor antagonists for peripheral pre- and postsynaptic dopamine receptors in the anesthetized dog. J Pharmacol Exp Ther. 1982 Jun;221(3):753–761. [PubMed] [Google Scholar]
  74. Shepperson N. B., Langer S. Z. The effects of the 2-amino-tetrahydronaphthalene derivative M7, a selective alpha 2-adrenoceptor agonist in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1981 Dec;318(1):10–13. doi: 10.1007/BF00503305. [DOI] [PubMed] [Google Scholar]
  75. Skärby T., Andersson K. E., Edvinsson L. Characterization of the postsynaptic alpha-adrenoceptor in isolated feline cerebral arteries. Acta Physiol Scand. 1981 May;112(1):105–107. doi: 10.1111/j.1748-1716.1981.tb06790.x. [DOI] [PubMed] [Google Scholar]
  76. Smellie F. W., Daly J. W., Wells J. N. 1-Isoamyl-3-isobutylxanthine: a remarkably potent agent for the potentiation of norepinephrine, histamine, and adenosine-elicited accumulations of cyclic AMP in brain slices. Life Sci. 1979 Nov 26;25(22):1917–1924. doi: 10.1016/0024-3205(79)90613-1. [DOI] [PubMed] [Google Scholar]
  77. Swedin G. Studies on neurotransmission mechanisms in the rat and guinea-pig vas deferens. Acta Physiol Scand Suppl. 1971;369:1–34. [PubMed] [Google Scholar]
  78. THESLEFF S. The effect of anesthetic agents on skeletal muscle membrane. Acta Physiol Scand. 1956 Nov 5;37(4):335–349. doi: 10.1111/j.1748-1716.1956.tb01369.x. [DOI] [PubMed] [Google Scholar]
  79. Tamargo J. Electrophysiological effects of bunaphtine on isolated rat atria. Eur J Pharmacol. 1980 Mar 7;62(1):81–88. doi: 10.1016/0014-2999(80)90483-5. [DOI] [PubMed] [Google Scholar]
  80. Topham J. C. Relationship between difference spectra and metabolism. Barbiturates, drug interaction and species difference. Biochem Pharmacol. 1970 May;19(5):1695–1701. doi: 10.1016/0006-2952(70)90160-7. [DOI] [PubMed] [Google Scholar]
  81. Tranzer J. P., Richards J. G. Ultrastructural cytochemistry of biogenic amines in nervous tissue: methodologic improvements. J Histochem Cytochem. 1976 Nov;24(11):1178–1193. doi: 10.1177/24.11.63507. [DOI] [PubMed] [Google Scholar]
  82. Tsuruta K., Frey E. A., Grewe C. W., Cote T. E., Eskay R. L., Kebabian J. W. Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor. Nature. 1981 Jul 30;292(5822):463–465. doi: 10.1038/292463a0. [DOI] [PubMed] [Google Scholar]
  83. Van Meel J. C., De Jonge A., Kalkman H. O., Wilffert B., Timmermans P. B., Van Zwieten P. A. Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol. 1981 Jan 16;69(2):205–208. doi: 10.1016/0014-2999(81)90415-5. [DOI] [PubMed] [Google Scholar]
  84. WALTER W. G., COOPER R., ALDRIDGE V. J., MCCALLUM W. C., WINTER A. L. CONTINGENT NEGATIVE VARIATION: AN ELECTRIC SIGN OF SENSORIMOTOR ASSOCIATION AND EXPECTANCY IN THE HUMAN BRAIN. Nature. 1964 Jul 25;203:380–384. doi: 10.1038/203380a0. [DOI] [PubMed] [Google Scholar]
  85. Waddington J. L., Gamble S. J. Emergence of apomorphine-induced 'vacuous chewing' during 6 months continuous treatment with fluphenazine decanoate. Eur J Pharmacol. 1980 Dec 5;68(3):387–388. doi: 10.1016/0014-2999(80)90541-5. [DOI] [PubMed] [Google Scholar]
  86. Waddington J. L., Gamble S. J. Prolonged dopamine receptor blockade in rats after termination of long-term depot fluphenazine. Lancet. 1981 Jun 20;1(8234):1375–1376. doi: 10.1016/s0140-6736(81)92558-7. [DOI] [PubMed] [Google Scholar]
  87. Wells J. N., Kramer G. L. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment. Mol Cell Endocrinol. 1981 Jul;23(1):1–9. doi: 10.1016/0303-7207(81)90112-x. [DOI] [PubMed] [Google Scholar]
  88. Westerink B. H., Korf J. Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs. Eur J Pharmacol. 1976 Aug;38(2):281–291. doi: 10.1016/0014-2999(76)90331-9. [DOI] [PubMed] [Google Scholar]
  89. Wilkinson G. R., Shand D. G. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975 Oct;18(4):377–390. doi: 10.1002/cpt1975184377. [DOI] [PubMed] [Google Scholar]
  90. Wistedt B., Wiles D., Kolakowska T. Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics. Lancet. 1981 May 23;1(8230):1163–1163. doi: 10.1016/s0140-6736(81)92334-5. [DOI] [PubMed] [Google Scholar]
  91. Wong P. Y., Lee W. H., Chao P. H., Reiss R. F., McGiff J. C. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification. J Biol Chem. 1980 Oct 10;255(19):9021–9024. [PubMed] [Google Scholar]
  92. Wong P. Y., Lee W. H., Quilley C. P., McGiff J. C. Metabolism of prostacyclin: formation of an active metabolite in the liver. Fed Proc. 1981 May 15;40(7):2001–2004. [PubMed] [Google Scholar]
  93. Woodruff G. N., Freedman S. B. Binding of [3H]sulpiride to purified rat striatal synaptic membranes. Neuroscience. 1981;6(3):407–410. doi: 10.1016/0306-4522(81)90133-0. [DOI] [PubMed] [Google Scholar]
  94. Woods P. B., Robinson M. L. An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents. J Pharm Pharmacol. 1981 Mar;33(3):172–173. doi: 10.1111/j.2042-7158.1981.tb13743.x. [DOI] [PubMed] [Google Scholar]
  95. Yavin E., Zutra A. Separation and analysis of 32P-labeled phospholipids by a simple and rapid thin-layer chromatographic procedure and its application to cultured neuroblastoma cells. Anal Biochem. 1977 Jun;80(2):430–437. doi: 10.1016/0003-2697(77)90665-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES